Verrica Pharmaceuticals Inc. (VRCA)
NASDAQ: VRCA · Real-Time Price · USD
0.694
+0.018 (2.65%)
At close: Dec 20, 2024, 4:00 PM
0.708
+0.014 (1.97%)
After-hours: Dec 20, 2024, 4:46 PM EST
Verrica Pharmaceuticals Stock Forecast
VRCA's stock price has decreased by -87.51% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 2 analysts with 12-month price forecasts for VRCA stock have an average target of 6.00, with a low estimate of 2.00 and a high estimate of 10. The average target predicts an increase of 764.30% from the current stock price of 0.69.
Analyst Consensus: Hold
* Price targets were last updated on Nov 5, 2024.
Analyst Ratings
The average analyst rating for VRCA stock from 5 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 2 | 1 |
| Buy | 1 | 1 | 1 | 1 | 0 | 0 |
| Hold | 0 | 0 | 0 | 2 | 4 | 4 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 6 | 6 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Needham | Needham | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Dec 20, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Nov 6, 2024 |
| Needham | Needham | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Nov 5, 2024 |
| RBC Capital | RBC Capital | Buy → Hold Downgrades $11 → $2 | Buy → Hold | Downgrades | $11 → $2 | +188.10% | Nov 5, 2024 |
| TD Cowen | TD Cowen | Strong Buy Maintains $15 → $10 | Strong Buy | Maintains | $15 → $10 | +1,340.51% | Oct 21, 2024 |
Financial Forecast
Revenue This Year
7.90M
from 5.12M
Increased by 54.16%
Revenue Next Year
15.78M
from 7.90M
Increased by 99.78%
EPS This Year
-1.63
from -1.48
EPS Next Year
-0.60
from -1.63
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 8.9M | 26.3M | 63.0M | |||
| Avg | 7.9M | 15.8M | 38.6M | |||
| Low | 7.1M | 9.0M | 18.1M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 74.2% | 232.3% | 299.2% | |||
| Avg | 54.2% | 99.8% | 144.8% | |||
| Low | 37.7% | 13.7% | 14.9% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | -1.55 | -0.32 | -0.03 | |||
| Avg | -1.63 | -0.60 | -0.38 | |||
| Low | -1.68 | -0.93 | -0.88 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | - | - | |||
| Avg | - | - | - | |||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.